How can global business leaders deliver on ambitions of growth and reinvention?
The biotech industry has expanded rapidly in the past decade, with investment in biotechnology and pharmaceutical firms pouring in from venture capitalists.
Going virtual – how COVID has accelerated a real shift in clinical trial methodology
Having risen to the COVID-19 challenge and reaped financial gains, firms could invest in R&D and grow their share in the global biotechnology market.
Having held a steady focus on personalised healthcare through its diagnostics unit, pharmaceutical giant Roche is digging deeper with data analytics.
Mark Allen, BUPA, and Andy Wolfe, Boyden UK Partner and leadership expert, provide key takeaways from Boyden UK's Human Resources virtual event
The pandemic has recast the pharmaceutical industry as a hero and led to faster adoption of digital technology, greater collaboration and more innovation.
The desire to stay active longer is driving innovation in joint replacement, which increasingly involves robotics and other advanced medical technology.
